Next Biomedical Co.,Ltd. (KOSDAQ:389650)
South Korea · Delayed Price · Currency is KRW 27,200
+750 (2.84%)
At close: Oct 23, 2026
Next Biomedical Market Cap
Next Biomedical has a market cap or net worth of 225.14 billion as of October 23, 2026. It is the 21,620th most valuable company in the world and the 764th biggest in South Korea. Its market cap has decreased by 56.92% in one year.
Market Cap
225.14B
Enterprise Value
197.10B
Revenue
17.79B
Global Rank
Country Rank
#764 South Korea
PE Ratio
957.39
ChartMarket Cap Chart
Since August 20, 2024, Next Biomedical's market cap has increased from 189.79B to 225.14B, an increase of 18.63%. That is a compound annual growth rate of 8.17%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 225.14B | -69.30% |
| Dec 30, 2025 | 733.43B | 121.21% |
| Dec 30, 2024 | 331.55B | 74.69% |
| Aug 20, 2024 | 189.79B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ASTERASYS Co.,Ltd | 191.90B |
| MEDIANA Co.,Ltd | 166.43B |
| L&K Biomed | 149.31B |
| Mezoo | 134.98B |
| Remed | 70.52B |
| Hironic | 70.34B |
| SELVAS Healthcare | 61.98B |
| DRGEM | 55.35B |